Antimicrobial treatment guidelines for acute bacterial rhinosinusitis - Executive summary

被引：285

作者：

Anon, JB ^{[1
]}

Jacobs, MR ^{[1
]}

Roche, R ^{[1
]}

Poole, MD ^{[1
]}

Merck, D ^{[1
]}

Ambrose, PG ^{[1
]}

Benninger, MS ^{[1
]}

Hadley, JA ^{[1
]}

Craig, WA ^{[1
]}

Andes, DR ^{[1
]}

Bernstein, JM ^{[1
]}

Besser, RE ^{[1
]}

Dowell, SF ^{[1
]}

Drusano, GL ^{[1
]}

Klepser, ME ^{[1
]}

Nicolau, D ^{[1
]}

Radowsky, A ^{[1
]}

Reller, LB ^{[1
]}

Wald, ER ^{[1
]}

Zucker, DR ^{[1
]}

机构：

[1] Sinus & Allergy Hlth Partnership, Washington, DC 20036 USA

来源：

OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2004年 / 130卷 / 01期

关键词：

D O I：

10.1016/j.otohns.2003.12.003

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

引用

页码：1 / 45

页数：45

共 159 条

[1]

ADDERSON EE, 2003, 43 INT C ANT AG CHEM

[2] Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives):: A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens [J].

Agouridas, C ;

Denis, A ;

Auger, JM ;

Benedetti, Y ;

Bonnefoy, A ;

Bretin, F ;

Chantot, JF ;

Dussarat, A ;

Fromentin, C ;

D'Ambrières, SG ;

Lachaud, S ;

Laurin, P ;

Le Martret, O ;

Loyau, V ;

Tessot, N .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :4080-4100

[3]

*AHCPR, 1999, DIAGN TREATM AC BACT

[4] Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore [J].

Albanese, BA ;

Roche, JC ;

Pass, M ;

Whitney, CG ;

McEllistrem, MC ;

Harrison, LH .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :15-21

[5]

AMBROSE P, 2003, 43 INT C ANT AG CHEM

[6] New antibiotics in pulmonary and critical care medicine: Focus on advanced generation quinolones and cephalosporins [J].

Ambrose, PG ;

Owens, RC .

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 21 (01) :19-32

[7] Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia [J].

Ambrose, PG ;

Quintiliani, R ;

Nightingale, CH ;

Nicolau, DP .

INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1998, 7 (09) :463-470

[8] Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction [J].

Ambrose, PG ;

Bhavnani, SM ;

Cirincione, BB ;

Piedmonte, M ;

Grasela, TH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) :435-440

[9] The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs:: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae [J].

Ambrose, PG ;

Grasela, DM .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (03) :151-157

[10] Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections [J].

Ambrose, PG ;

Grasela, DM ;

Grasela, TH ;

Passarell, J ;

Mayer, HB ;

Pierce, PF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2793-2797

← 1 2 3 4 5 6 7 8 9 10 →